Background High levels of expression in hepatocytes can be achieved after i
ntraportal delivery of plasmid DNA vectors with up to 10% of all liver cell
s transfected. CMV promoter-driven expression is very high on Day 1 after i
njection, but is diminished strongly by Day 2. Expression slowly declines a
fter 1 week. We describe experiments aimed at elucidating the reasons for t
his rapid decline in transgene expression.
Methods Histological methods were used to determine the presence and extent
of Liver damage and hepatocyte proliferation. Viral and liver-specific pro
moters were tested to study promoter shut-off, Southern blotting was perfor
med to determine the loss of the pDNA vector over time, and several mouse m
odels were used to study the host immunological response.
Results pDNA is lost rapidly early after injection, but remains at a relati
vely stable copy number after Day 4. Southern blotting experiments showed t
hat plasmid DNA could be detected for at least 12 weeks after injection (0.
2 copies per genome). The early rapid decline of expression is promoter dep
endent. A liver-specific albumin promoter resulted in similar levels of exp
ression on Days 1 and 7, suggesting that promoter inactivation may be respo
nsible for the instability of CMV promoter-driven expression. The slow decl
ine in expression levels after 1 week appears to be the result of an immune
response directed against the expressed transgene. Expression was much pro
longed in immunosuppressed, immunodeficient, or antigen-tolerized mice.
Conclusion The present data suggest that if promoter inactivation can be ov
ercame, intravascular delivery of plasmid DNA could be a highly efficient,
simple and non-toxic liver gene therapy approach. Intravascular delivery of
pDNA allows for the rapid screening of novel expression vectors in vivo. C
opyright (C) 2001 John Wiley & Sons, Ltd.